Cardiac performance in patients hospitalized with COVID‐19: a 6 month follow‐up study
A Fayol, M Livrozet, P Boutouyrie, H Khettab… - ESC heart …, 2021 - Wiley Online Library
Aims Myocardial injury is frequently observed in patients hospitalized with coronavirus
disease 2019 (COVID‐19) pneumonia. Different cardiac abnormalities have been reported …
disease 2019 (COVID‐19) pneumonia. Different cardiac abnormalities have been reported …
COVID-19 and cardiovascular disease: from bench to bedside
A pandemic of historic impact, coronavirus disease 2019 (COVID-19) has potential
consequences on the cardiovascular health of millions of people who survive infection …
consequences on the cardiovascular health of millions of people who survive infection …
Renin-angiotensin-aldosterone system and COVID-19 infection
With the multiplication of COVID-19 severe acute respiratory syndrome cases due to SARS-
COV2, some concerns about angiotensin-converting enzyme 1 (ACE1) inhibitors (ACEi) and …
COV2, some concerns about angiotensin-converting enzyme 1 (ACE1) inhibitors (ACEi) and …
Renin–angiotensin–aldosterone system inhibitors in patients with Covid-19
RAAS Inhibitors in Patients with Covid-19 The effects of renin–angiotensin–aldosterone
system blockers on angiotensin-converting enzyme 2 levels and activity in humans are …
system blockers on angiotensin-converting enzyme 2 levels and activity in humans are …
Late phase of COVID‐19 pandemic in General Cardiology. A position paper of the ESC Council for Cardiology Practice
D Richter, L Guasti, F Koehler, A Squizzato… - ESC Heart …, 2021 - Wiley Online Library
Cardiovascular (CV) engagement in coronavirus disease 2019 (COVID‐19) is a huge
determinant of prognosis during the acute phase of the disease. However, little is known …
determinant of prognosis during the acute phase of the disease. However, little is known …
Cardiovascular disease and COVID-19: a consensus paper from the ESC working group on coronary pathophysiology & microcirculation, ESC working group on …
E Cenko, L Badimon, R Bugiardini… - Cardiovascular …, 2021 - academic.oup.com
The cardiovascular system is significantly affected in coronavirus disease-19 (COVID-19).
Microvascular injury, endothelial dysfunction, and thrombosis resulting from viral infection or …
Microvascular injury, endothelial dysfunction, and thrombosis resulting from viral infection or …
Organ‐protective effect of angiotensin‐converting enzyme 2 and its effect on the prognosis of COVID‐19
H Cheng, Y Wang, GQ Wang - Journal of medical virology, 2020 - Wiley Online Library
This article reviews the correlation between angiotensin‐converting enzyme 2 (ACE2) and
severe risk factors for coronavirus disease 2019 (COVID‐19) and the possible mechanisms …
severe risk factors for coronavirus disease 2019 (COVID‐19) and the possible mechanisms …
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID‐19. Results of the Cardio‐COVID‐Italy multicentre study
D Tomasoni, RM Inciardi, CM Lombardi… - European journal of …, 2020 - Wiley Online Library
Aims To assess the prognostic value of a history of heart failure (HF) in patients with
coronavirus disease 2019 (COVID‐19). Methods and results We enrolled 692 consecutive …
coronavirus disease 2019 (COVID‐19). Methods and results We enrolled 692 consecutive …
Cardiac involvement in COVID‐19 patients: Risk factors, predictors, and complications: A review
Background Respiratory complications have been well remarked in the novel coronavirus
disease (SARS‐CoV‐2/COVID‐19), yet an emerging body of research indicates that cardiac …
disease (SARS‐CoV‐2/COVID‐19), yet an emerging body of research indicates that cardiac …
Angiotensin-converting enzyme 2 (ACE2): COVID 19 gate way to multiple organ failure syndromes
Background Globally, the current medical emergency for novel coronavirus 2019 (COVID-
19) leads to respiratory distress syndrome and death. Purpose This review highlighted the …
19) leads to respiratory distress syndrome and death. Purpose This review highlighted the …